DF
Donoghue Forlines’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.43M | Sell |
7,693
-9,791
| -56% | -$1.82M | 0.41% | 95 |
|
|
2025
Q1 | $3.66M | Buy |
17,484
+8,462
| +94% | +$1.77M | 1.16% | 12 |
|
|
2024
Q4 | $1.6M | Buy |
9,022
+1,131
| +14% | +$201K | 0.54% | 55 |
|
|
2024
Q3 | $1.56M | Buy |
7,891
+276
| +4% | +$54.5K | 0.44% | 54 |
|
|
2024
Q2 | $1.31M | Buy |
7,615
+118
| +2% | +$20.2K | 0.37% | 76 |
|
|
2024
Q1 | $1.37M | Buy |
7,497
+1,398
| +23% | +$255K | 0.39% | 79 |
|
|
2023
Q4 | $945K | Sell |
6,099
-216
| -3% | -$33.5K | 0.3% | 89 |
|
|
2023
Q3 | $941K | Buy |
6,315
+641
| +11% | +$95.5K | 0.34% | 91 |
|
|
2023
Q2 | $764K | Buy |
5,674
+2,322
| +69% | +$313K | 0.24% | 94 |
|
|
2023
Q1 | $534K | Sell |
3,352
-186
| -5% | -$29.6K | 0.19% | 127 |
|
|
2022
Q4 | $572K | Sell |
3,538
-1,132
| -24% | -$183K | 0.2% | 149 |
|
|
2022
Q3 | $627K | Sell |
4,670
-7,579
| -62% | -$1.02M | 0.23% | 79 |
|
|
2022
Q2 | $1.88M | Sell |
12,249
-3,877
| -24% | -$594K | 0.49% | 30 |
|
|
2022
Q1 | $2.61M | Buy |
16,126
+3,089
| +24% | +$501K | 0.57% | 29 |
|
|
2021
Q4 | $1.77M | Sell |
13,037
-1,732
| -12% | -$234K | 0.3% | 79 |
|
|
2021
Q3 | $1.59M | Buy |
14,769
+64
| +0.4% | +$6.9K | 0.31% | 83 |
|
|
2021
Q2 | $1.66M | Buy |
14,705
+340
| +2% | +$38.3K | 0.31% | 84 |
|
|
2021
Q1 | $1.56M | Sell |
14,365
-842
| -6% | -$91.1K | 0.3% | 83 |
|
|
2020
Q4 | $1.63M | Buy |
+15,207
| New | +$1.63M | 0.31% | 54 |
|
|
2020
Q1 | – | Sell |
-25,185
| Closed | -$2.23M | – | 61 |
|
|
2019
Q4 | $2.23M | Buy |
+25,185
| New | +$2.23M | 0.35% | 110 |
|
|
2018
Q1 | – | Sell |
-27,236
| Closed | -$2.63M | – | 143 |
|
|
2017
Q4 | $2.63M | Sell |
27,236
-188,545
| -87% | -$18.2M | 0.2% | 88 |
|
|
2017
Q3 | $19.2M | Sell |
215,781
-14,477
| -6% | -$1.29M | 2.02% | 7 |
|
|
2017
Q2 | $16.7M | Buy |
+230,258
| New | +$16.7M | 1.89% | 10 |
|